Conferences  >  Medicine & Healthcare  >  Oncology

Miami Cancer Institute

The Miami Brain Symposium will focus on state-of-the-art approaches to the management of primary and metastatic central nervous systems tumors, along with an understanding of current standards of care and a look at future directions. This symposium will engage participants as the expert faculty navigate through complex cases, novel treatment strategies, and panel discussions.

Phone: [786-596-1285];     Email: eleanora@baptisthealth.net

Oncology, Brain tumor, Symposium, Medical Symposium, continuing medical education,

Continuing Medical Education (CME),    Continuing Medical Education (CME)

European Society for Translational Medicine

The European Society for Translational Medicine (EUSTM) cordially invites you to attend the 11th Annual Congress of the European Society for Translational Medicine on Immunotherapeutics – From Biology to Patient Care (EUSTM-2024) held in virtual format during 6-8 September, 2024. The Congress will focus on recent advances in the field of immunotherapeutics for solid tumors, hematological malignancies, autoimmune disorders, infectious disease, Covid, & vaccines covering from biological research, diagnostics & biomarkers to clinical care. EUSTM-2024 not only provides a unique platform for scientific exchange and discussion about the recent progress in both bench and bed side of immunotherapies for cancer and infectious diseases, but also an avenue for global networking with key stakeholders in academic research, clinical care giver, public health workers, and industrial leaders.

Phone: [+43 1 8923 562];     Email: immuno-2024@eutranslationalmedicine.org

solid tumors, hematological malignancies, autoimmune disorders, infectious disease, Covid, vaccines biological research, diagnostics, biomarkers, clinical care, Immunology, MIcrobiology, life sciences, Molecular Biology, Cancer, Blood Cancers, Breast cancer, Lungs Cancer, Ovarian cancer, GIT cancer, Brain cancer, Genitourinary cancer, prostate cancer, bladder cancer,

Immunology and Allergic Diseases,    Medicine (in general), Internal medicine

Jožef Stefan Institute

As in previous editions of the conference, the ICPM will bring together professionals from the fields of plasma, medicine, biology and biochemistry in order to develop a common language, to better define key challenges and open questions and to move toward effective solutions. This time it will be organized jointly with IWPCT covering plasma for cancer therapy on Monday, Sep. 9th. Prior to the conference, the traditional Summer School will take place, starting on the weekend, Sunday, Sep. 8th, and going through mornings from Monday, Sep. 9th to Wednesday, Sep. 11th. Registrations for the summer school will be conducted separately from the registrations for the conference.

Email: icpm10@ijs.si

plasma, medicine, cancer treatment,

Plasma and Gas-discharge Physics, Nuclear Fusion,    Medicine (in general), Internal medicine

European Helicobacter and Microbiota Study Group

The European Helicobacter and Microbiota Study Group (EHMSG) is a multidisciplinary group composed of representatives from most countries of the EU. It was founded in 1987 by a collaboration of pioneers in the field of Helicobacter and expanded its remit in 2016 to embrace the collective gastrointestinal microbiota. This includes dissemination of medical, scientific and technical information in order to promote health and decrease the burden of digestive diseases.

Each year, EHMSG hosts a conference consisting of a one-day postgraduate course followed by a 2-day workshop.

Event Secretariat;     Phone: [+431405138318];     Email: workshop@ehmsg.org

Helicobacter, Microbiota, IBD, FMT

Gastroenterology,    Medicine (in general), Internal medicine

Fields Institute

This workshop aims to take a closer look at how mathematical and computational models can help answer clinically relevant questions and enhance multimodal treatments. Currently, a wide range of modelling approaches study cancer and have a crucial role in treatment delivery from answering questions related to cancer biology and treatment efficacy to directly helping with treatment delivery. In this workshop, we would like to bring together clinicians, biomedical experts, experimentalists, and mathematicians to explore some of the relevant questions on multimodal treatment modelling, efficacy, optimization, drug resistance and clinical delivery.

Modeling and Simulation,    Systems Biology and Computational Biology

European Society of Oncologic Imaging

The ESOI Touchdown 2024 event is an annual meeting organized by the European Society of Oncologic Imaging, where participants can follow various lectures by leading scholars and practitioners on oncologic imaging.

ESOI Office;     Email: office@esoi-society.org

radiology, oncologic imaging, oncology

Binaytara Foundation

The “BTF Northwest Women’s Cancer Conference” is a CME-accredited activity featuring experts in breast cancer and gynecologic malignancies. The goal of this activity is to improve the knowledge and competence of learners to apply practice-changing clinical data and expert recommendations to optimize clinical outcomes for patients with breast cancer and gynecologic malignancies. The program features in-depth discussion and analysis of the latest scientific findings and practice-changing advances in the field. Expert faculty will aim to place the role of different therapeutic agents in the clinical context and discuss how to utilize these therapeutic options to effectively contribute to patient care. This women's cancer conference will augment healthcare providers’ foundation of knowledge and clinical competence in the management of women’s cancers.

Phone: [425-616-0572];     Email: cme@binayfoundation.org

Breast Cancer, Gynecologic Malignancies, Oncology

Continuing Medical Education (CME),    Obstetrics/Gynecology

Binaytara Foundation

This CME-accredited activity Cellular Therapy in Hematology and Oncology: Expert Guidance for Clinical Practice features leading experts in hematologic malignancies and cellular therapies who will provide a comprehensive overview of current and emerging strategies for the management of lymphoma, myeloma, acute leukemias, and solid tumors with a focus in the use of cellular therapies. The goal of this activity is to improve the knowledge and competence of learners to apply practice-changing clinical data and expert recommendations to optimize clinical outcomes for patients with hematologic malignancies and to describe potential future applications of cellular therapy in solid tumors. The activity will use a mix of didactic lectures and case-based discussions to highlight areas of debate between cellular therapy and non-cellular therapy in the treatment of these diseases. Expert faculty will aim to place the role of different therapeutic agents in a clinical context and discuss how to utilize these therapeutic options to effectively contribute to patient care. This conference is designed to provide physicians, physician assistants, nurse practitioners, pharmacists, nurses, and other healthcare professionals with the latest updates in the field. It will highlight a multidisciplinary approach and the integration of new advances in patient-centered care.

Phone: [425-616-0572];     Email: cme@binayfoundation.org

Cellular Therapy, Oncology, Hematology, Lymphoma, Myeloma, Acute Leukemia

Continuing Medical Education (CME),    Hematology

The European Association for Cancer Research (EACR)

This conference will explore a breadth of new technical approaches to the identification and development of novel cancer therapeutics, including agents in early clinical development. The aim is to provide an accessible insight into recent developments in this rapidly evolving field, that aims to harness our insights from cancer research for the benefit of patients. The target audience for this conference is: scientists in academia and industry who are interested in the most recent developments in cancer therapeutic discovery, including small molecule, degrader, peptide, and antibody technologies. The conference will include several novel antitumour approaches in early clinical development. Join us online on 24 and 25 September to learn more about this fascinating topic from world-renowned speakers! Submit your abstract before 29 July and register before 09 September to secure your place.

Conference Officer: Hannah Barrs;     Phone: [N/A];     Email: hannah.barrs@eacr.org

cancer research, oncology, therapeutic targets, cancer drug discovery, drug discovery approaches, new technical approaches to cancer therapeutics, early clinical development, small molecule technology, phenotypic screens, covalent fragment screens, degrader technology, PROTAC, molecular glue, peptide technology, oral cyclic peptide inhibitors, antibody technology, antitumour approaches, antibody drug conjugates, targeting RAS, targeting mutant p53.

kenes exhibitions

The RNA Therapeutics Symposium aims to harness the transformative potential of RNA technology for a broader spectrum of cancer therapeutics. Bringing together a diverse array of experts, including RNA biologists, systems analysts, immunologists, and drug development specialists, this event fosters a collaborative environment. It facilitates the exchange of cutting-edge research, the development of a unified scientific lexicon, and the acceleration of research and development efforts in RNA therapeutics.

Phone: [+972 74 745 7435];     Email: skrein@kenes-exhibitions.com

RNA Therapeutics RNA Vaccines  RNA medicines RNA Manufacturing RNA technologies immunology Biotech Cancer

Conventus Congressmanagement & Marketing GmbH

Conventus Congressmanagement & GmbH;     Email: conferencemarketing@conventus.de

Binaytara Foundation

This CME-accredited activity, Park City Lymphoma Myeloma Conference, features leading experts in hematologic malignancies who will provide a comprehensive overview of current and emerging strategies for the management of multiple myeloma, lymphoma, and Waldenström Macroglobulinemia. This activity aims to improve learners' knowledge and competence to apply practice-changing clinical data and expert recommendations to optimize clinical outcomes for patients with hematologic malignancies. The program features in-depth discussion and analysis of the latest scientific findings and practice-changing advances in newly diagnosed and relapsed multiple myeloma and lymphomas with a focus on emerging immunotherapies, including but not limited to CAR-T therapy and T-cell redirecting bispecific antibodies. Expert faculty will aim to place the role of different therapeutic agents in clinical contexts and discuss how to utilize these therapeutic options to effectively contribute to patient care.

Phone: [425-616-0572];     Email: cme@binayfoundation.org

Oncology, Hematology, Lymphoma, Myeloma, Waldenström Macroglobulinemia

Hematology,    Continuing Medical Education (CME)

Fields Institute

This workshop explores research in methods aimed at connecting mathematical models of cancer evolution and clinical data. It focuses on ecology and evolution of cancer. Traditionally, ecology and evolution have been the most “mathematical” (and perhaps the first mathematical) areas of biology. Mathematical contributions to these fields made in the 20th century are now fundamental parts of scientific knowledge. More recently, methods of ecology and evolution have found their way into oncology, bridging traditional molecular biology and mathematics including stochastic processes, dynamical systems, and nonlinear partial differential equations. New biological challenges lead to difficult mathematical problems and beautiful solutions, which are both innovative mathematically and impactful from the point of view of public health. These will be the focus of the proposed workshop .

Modeling and Simulation,    Systems Biology and Computational Biology

Binaytara Foundation

The 4th Binaytara Precision Oncology Summit is a 2-day CME-accredited conference that offers an unparalleled opportunity for oncology professionals to delve into the latest advancements, innovations, and practices in precision oncology. The theme for this year's summit, "Current Standards and Emerging Therapies," highlights the conference's commitment to providing a comprehensive overview of the field, including in-depth discussions on the latest developments in precision oncology, alongside a thorough examination of established treatment protocols. Focus on actionable mutations ensures that the presented information translates directly into improved patient care. The summit features didactics, panel discussions, interactive case studies, and scientific abstract presentations.

Phone: [425-616-0572];     Email: cme@binayfoundation.org

cancer, oncology, CME, continuing medical education

The European Association for Cancer Research

This conference will gather top experts in the field of cancer metabolism to discuss the metabolic alterations in tumours and how we can exploit this to treat cancer. Topics to be covered include: metabolic reprogramming in cancer beyond anabolism, metabolic transformation in cancer cells, metabolic signalling in cancer, metabolic cross-talk in the tumour microenvironment, metabolic regulation of gene expression, immune cell metabolism in cancer, nucleotide metabolism and cancer, metabolic approaches to cancer therapy, and systemic metabolic changes and their effects on cancer progression. The target audience for this conference is basic and translational scientists and clinicians, both senior and young investigators that want to have a broad and detailed overview of the most recent advances in the field of cancer metabolism.

Conference Officer: Chris Iliffe;     Phone: [N/A];     Email: christopher.iliffe@eacr.org

cancer metabolism, adaptations of cancer, tumour biology, tumour vulnerabilities, cancer cell biology, stromal cell biology, metabolic cell wiring, cell anabolism, molecular properties of cancer cells, cancer genomics, cancer cell signalling, nutrient signalling, cancer metabolic alterations, metabolic cross-talk, the tumour microenvironment, the tumour macroenvironment, gene expression, immune cell metabolism, metabolic approaches to cancer therapy, cancer progression, cancer research, oncology

CHI

Join us for an exclusive gathering of senior-level investors, corporate executives, entrepreneurs, and business leaders at Oncology Venture, Innovation & Partnering Summit. Connect with future investors and partners at intimate networking sessions; gain strategic insights on funding activities, exits, business development, and innovation strategies in cancer therapeutics and diagnostics from industry-led panels; and hear candid perspectives and business recommendations from oncology thought leaders during dynamic fireside chats.

Phone: [781.972.5400];     Email: chi@healthtech.com

Jefferson University

The 6th Annual Jefferson Health Lung Cancer Screening Summit aims to review the latest knowledge and research advances in the field by bringing together a multi-disciplinary group of physicians, nurses, program coordinators, researchers, and other experts. The vision for the Jefferson Health Annual Lung Cancer Screening Summit is to develop a nationally recognized educational program that brings together clinicians and researchers focused on early detection of lung cancer.

Fields Institute

Immunotherapies have revolutionized treatments for several types of cancers, but have been met with clinical trial failures in others. The idea of eliciting an immune response against a tumour is old, but we are only just beginning to harness the potential of the immune system to treat both solid and liquid tumours. To improve immunotherapeutic approaches requires understanding how the immune system interacts around and within a tumour, allowing us to establish effective immunotherapeutic protocols. Mathematical modelling can help identify the mechanisms at the heart of immunotherapeutic efficacy and design successful therapeutic regimens. Close collaboration between experimentalists, clinicians, and quantitative researchers in academia and industry is required to forward models for implementation. This workshop will focus on tightening the links between researchers in different fields to fuel immunotherapy success.

Modeling and Simulation,    Systems Biology and Computational Biology

CRUK, ESMO, Unicancer

MAP focuses on current and emerging approaches in precision oncology, highlights successes and challenges, and proposes potential solutions in clinical research and practice. This event constitutes an excellent occasion to reunite basic scientists, people working on new technologies, medical doctors, and healthcare providers.

Phone: [+41 (0)91 973 19 47];     Email: map@esmo.org

cancer biology, translational research, molecular pathology, clinical research, immunotherapy, personalised cancer medicine, precision medicine, precision oncology, tumour immunology, anticancer agents, basic science, biological therapy, laboratory medicine, genetic counselling, tumour response evaluation, imaging, molecular imaging, epigenetics, tumours evolution, KRAS, molecular characterisation, clonal evolution, microenvironment in metastasis, myeloid targets for immunotherapy, transcription inhibitors, translation inhibitors, therapeutic targeting, early detection, molecular profiling

As usual, the annual EANO meeting will kick off with an Educational Day on Thursday, October 17 and the main programme will commence on Friday, October 18. The congress encourages exchange and collaboration between all relevant disciplines: Neuro-Oncology, Neurosurgery, Neuropathology, Neuroradiology and Radiation Oncology as well as Nursing and other Allied Health Professionals, and aims to bring together scientific and clinical expertise and research to bridge gaps in our understanding and management of central nervous system tumours. EANO is Europe’s multidisciplinary Neuro-Oncology organisation representing all medical and scientific disciplines involved in the prevention, diagnosis, and treatment of tumours of the central nervous system. The successful 2023 EANO meeting in Rotterdam attracted more than 1000 participants from all continents and was very highly rated!

Binaytara Foundation

This accredited continuing education activity, the Santa Fe Precision Oncology Symposium, is designed to improve the care of cancer patients by educating cancer care providers about precision oncology. This oncology conference features leading experts in the field of precision oncology who will provide a comprehensive overview of the implications of actionable molecular alterations across common malignancies. This activity is designed to facilitate learning, improve knowledge retention, and inspire participants to implement the newly acquired knowledge into their clinical practice. Through didactic lectures, case-based discussions, and interactive questions and answer sessions, participants will be able to ask relevant questions, clarify concerns, and network with expert faculties.

Phone: [425-616-0572];     Email: cme@binayfoundation.org

Oncology, Precision Oncology, Hematology, Malignancies, Continuing Medical Education (CME)

Strategic Healthcare Advisors

36th Annual Fall Foliage Cancer Conference - Update on Prostate and Genitourinary Cancers is an approved CME program. It will be held in Asheville, NC on October 25-26, 2024 at the Omni Grove Park Inn Resort & Spa. We have been approved for 10.0 AMA PRA Category 1 Credit. Speakers are top of their field from Harvard, Cleveland Clinic, Memorial Sloan Kettering, Duke, Mt Sinai, NYU Langone, UNC, Cornell Weill and Vanderbilt.

Phone: [8282779706];     Email: dwwillis@shallc.net

World Class CME

Participants will receive guided instruction in hand-held ultrasound, contrast enhanced mammography and automated breast ultrasound interpretation. Experience hands-on, advanced tools using 2D, 3D and AI for both screening and diagnostic breast ultrasound. Participants will receive guided instruction in breast ultrasound interpretation , as well as contrast-enhanced mammography by expert faculty.

Phone: [8882079105];     Email: office@worldclasscme.com

CME, World Class CME, Ultrasound, CEM, Breast, Nashville

Continuing Medical Education (CME),    Radiology, Nuclear Medicine and Radiation Therapy

Coalesce Research Group

We are glad to announce the 4thEuropean Congress on Cancer and Oncology Research on October 28-29, 2024 at Rome, Italy with the theme “Breaking Barriers: Collaborative Approaches in Cancer Research”. Our Aim is to bring global scientists/ researchers and business professionals to one platform. Oncology Research 2024 includes the series of B2B & B2C meetings, Oral Talks, Poster Presentations, and Workshops & Exhibitions by Industries, Academicians, Professors, and Young Forum Researchers & Students.by providing collaboration spaces and break-out rooms with tea and lunch for speakers, and delegates between sessions with invaluable networking time for you.

Phone: [1-718-543-9362];     Email: sarahlivingstone178@gmail.com

Cells and Cell Structure Cancer Systems Biology Sarcoma Colorectal Cancer Breast-cancer Blood cancer Skin cancer Gynecologic Cancer Head and Neck Cancer Genetic Cancer Nanotechnology in cancer Organ Specific Cancer Pediatric Oncology Medical Oncology Radiation Oncology Neuro Oncology Tissue regeneration and Oncology Cancer Epidemiology Cancer Treatment & Therapy Covid & Its impact on cancer Cancer Immunotherapies Cancer Biomarkers Cancer Metastasis Cancer drugs Market Tumor Virology and Immunology Radiology and Medical Imaging Cancer Chemotherapy and Pharmacology

Binaytara Foundation

This CME-accredited activity, the 2024 Seattle Lung Cancer Conference, brings together leaders in the field of thoracic oncology to provide an extensive overview of both current and emerging strategies for managing lung cancer (NSCLC and SCLC). The primary aim of this conference is to enhance the knowledge and competence of participants, enabling them to apply practice-changing clinical data and expert recommendations to optimize clinical outcomes for lung cancer patients. The program includes detailed discussions and analyses of the latest scientific discoveries and advancements in molecular testing and targeted therapies for thoracic oncology. The expert faculty will focus on the clinical application of diagnostics, biomarkers, and various therapeutic agents, discussing how these tests and treatments can be effectively used to improve patient care.

Phone: [425-616-0572];     Email: hanna.k@binayfoundation.org

Lung Cancer, Oncology, NSCLC, SCLC, CME, Continuing Medical Education

Spandidos Publications

ISMM28 will focus on the latest research findings and cutting-edge technologies in the field of molecular medicine, with leading experts and scholars gathering from all over the world. ISMM28 creates a broad academic platform where participants will have the opportunity to share their research results, exchange academic views, and discuss the future direction of molecular medicine.

Organizing Committee;     Phone: [+86-15361286025];     Email: jiangjie@yujiab.com

Molecular medicine, oncology, SCI, academic conferences

Medizinisches Zentrallabor – Abteilung Transfusionsmedizin und Klinische Hämostaseologie, Klinik für Hämatologie, Zelltherapie und Hämostaseologie Bereich Hämostaseologie, MVZ Labor Dr. Reising-Ackermann und Kollegen

event lab. GmbH;     Phone: [0341 30 88 84 62];     Email: asauerland@eventlab.org

Hematology,    Vascular Medicine, Angiology

Fraunhofer Institute for Cell Therapy and Immunology, University Hospital Leipzig

The Leipzig Immune ONcology (LION) Conference will bring together clinicians, scientists and industry to discuss latest developments and highlights on special issues of immune oncology. The annual meeting is organized by the Fraunhofer Institute for Cell Therapy and Immunology and the University Hospital Leipzig.

Fraunhofer Institute for Cell Therapy and Immunology, Jens Augustin;     Email: info@lion-conference.com

oncology, immunotherapy, gene therapy, cell therapy

Immunology and Allergic Diseases,    Stem-cell Research & Therapy

Fraunhofer Institute for Cell Therapy and Immunology; Leipzig University Cancer Center (UCCL)

The Leipzig Immune ONcology (LION) Conference will bring together clinicians, scientists and industry to discuss latest developments and highlights on special issues of immune oncology. The annual meeting is organized by the Fraunhofer Institute for Cell Therapy and Immunology and the University Cancer Center of the University Hospital Leipzig.

Conference office: event lab. GmbH;     Phone: [+49 341 30 8884-72];     Email: info@lion-conference.com

cancer immuno therapy, immune oncolocgy

The European Association for Cancer Research

Our popular Liquid Biopsies series returns for its fourth edition to bring together a slate of recognised experts who will explore how complex multi-modal liquid biopsy assays could be taken from the laboratory into clinical practice. Topics to be covered include the implementation of liquid biopsy in clinical trials, the various applications for CTCs, the basic biology of biomarker discovery, new techniques enhancing liquid biopsy, the integration of multiple blood-based analytes for multi-modal biomarkers, and how artificial intelligence can be applied to the field. This conference is suitable for a wide audience including translational scientists, researchers working in genetics, biology, molecular pathology, bioengineering, and data science, as well as clinical and non-clinical trainees, primary care physicians, radiologists, patient advocates, and colleagues from industry working in biotechnology, diagnostics, and pharmaceuticals.

Conference Officer: Hannah Barrs;     Phone: [N/A];     Email: hannah.barrs@eacr.org

liquid biopsy, cancer research, oncology, translational research, clinical trials, clinical practice, early detection of cancer, cancer screening techniques, multi-modal assays, treatment efficacy vs resistance, treatment toxicity, cell-free DNA, cfRNA, CTCs, extracellular vesicles, extracellular proteins, blood-based analytes, AI in cancer detection and screening

Binaytara Foundation

The Binaytara Foundation is excited to announce the Binaytara Global Oncology Summit, a one-day CME-accredited conference dedicated to addressing cancer care in low and middle-income countries (LMICs). This summit will bring together leading oncology experts, healthcare professionals, and researchers interested in global oncology to discuss innovative solutions and strategies to improve cancer care in resource-limited settings.

Phone: [425-616-0572];     Email: cme@binayfoundation.org

oncology, cancer, global oncology

European Society of Head and Neck Radiology – ESHNR

The content of the 2024 Masterclass will focus more on the skull base region. This meeting will explore refresher and challenging areas with particular reference to upper aerodigestive tract, soft tissue neck, oncology and neck glands. The programme will include short lectures highlighting recent developments, imaging techniques, relevant anatomy and pathology, followed by case-based discussion in small-group workshops giving you the opportunity to ask questions and receive feedback. Aimed at Radiologists with an interest in, and experience of, head and neck radiology, this course will help all those who wish to brush-up on their anatomy, learn about latest developments and add value and structure to their imaging reports.

Phone: [+43 1 5334064-918];     Email: office@eshnr.eu

upper aerodigestive tract, soft tissue neck, oncology, neck glands, skull base, head and neck, radiology

Radiology, Nuclear Medicine and Radiation Therapy,    Continuing Medical Education (CME)

The European Association for Cancer Research (EACR)

This conference aims to illuminate the intricate dynamics between ageing and cancer, fostering interdisciplinary dialogue among researchers and clinicians. By understanding the biological dimensions of cancer in ageing populations, we aspire to drive innovations in prevention, diagnosis, and treatment strategies. Ultimately, the conference seeks to catalyse collaborative efforts to confront the unique challenges posed by cancer in the ageing world, with the overarching goal of improving the quality of life and outcomes for elderly cancer patients. This conference is relevant for a diverse range of researchers, clinicians, and industry professionals. We look forward to being joined by: scientists and academics working in oncology, gerontology, genetics, and related disciplines; clinical oncologists, geriatricians, and other healthcare professionals who play a crucial role in diagnosing, treating, and supporting elderly patients with cancer; and representatives from pharmaceutical companies and biotechnology firms which develop innovative therapies and technologies to combat cancer in ageing populations. Join us online on 03 and 04 December to learn more about this fascinating topic from world-renowned speakers! Submit your abstract before 14 October and register before 11 November to secure your place.

Conference Officer: Chris Iliffe;     Phone: [N/A];     Email: christopher.iliffe@eacr.org

cancer research, oncology, ageing, ageing hallmarks, senescence, immunosenescence, inflammaging, aged tumour microenvironment, cancer prevention, cancer diagnosis, cancer treatment, elderly patients, treatment advances

ESMO - European Society for Medical Oncology

ESMO Asia is an annual congress specifically focused on multidisciplinary oncology in the Asian region. ESMO Asia 2024 will feature scientific sessions covering a wide range of topics related to oncology, including advances in cancer research, new treatment modalities, and discussions on the management of specific types of cancer. Its educational sessions will provide in-depth training and insights into specific aspects of oncology, ensuring that participants gain practical knowledge that they can apply in their daily practice.

ESMO Asia 2024 Secretariat;     Email: asiacongress@esmo.org

oncology, translational research, clinical trials, breast cancer, CNS, precision medicine, gastrointestinal tumours, genitourinary tumours, gynecological tumours, haemathological malignancies, head and neck cancers, immunotherapy, melanoma, sarcoma, rare tumours, thoracic cancer, supportive care, palliative care, Clinical Practice Guidelines, radiology

Translational Medicine, Clinical Trials,    Continuing Medical Education (CME)

The European Association for Cancer Research (EACR), in conjunction withAstraZeneca

Conference Officer: Hannah Barrs;     Email: hannah.barrs@eacr.org

cancer research, oncology, circulating tumour DNA, cell-free DNA, liquid biopsy, early cancer detection, clinical trial design, breast cancer, lung cancer, colorectal cancer, bladder cancer, virtual cancer research conference

Abcam

This two-day academic conference owill bring together researchers to explore the complex interactions between metabolic reprogramming and cancer biology. This event aims to foster collaboration and inspire new approaches in cancer research and treatment. The conference will feature sessions on four critical topics: host-tumor interaction, immunometabolism & tumor microenvironment, tumor initiation, therapy & progression, and diet & nutrient transporters. Short talk and poster presentation opportunities are available for in-person attendees. Visit the website for more information.

Abcam Events;     Email: events@abcam.com

cancer, metabolism, immunometabolism, tumor microenvironment, host-tumor interaction, diet transporters, cancer biology, metabolic reprogramming

The European Association for Cancer Research and Boehringer Ingelheim

We return to this topic for its second edition to focus on the basic and clinical aspects of the regulation of the Mitogen Activated Protein Kinase (MAPK) pathway, one of the most commonly mutated signalling pathways in human cancers. The programme will include new insights about the mechanisms of action of the new generation of pan-RAS inhibitors and rational combination therapies.

Email: christopher.iliffe@eacr.org

cancer research, oncology, MAPK pathway, small molecule inhibitors, intrinsic resistance, adaptive resistance, effective cancer therapy agents, pan-RAS inhibitors, gene regulation, target validation, drug development, clinical and translational opportunities, rational combination therapies, cross-resistance to immune modulators

Molecular Biology,    Pharmacology and Drug Development

The European Association for Cancer Research (EACR)

This meeting will delve into the profound consequences cancer can have on the body’s usual functions, and the underlying mechanisms behind these systemic effects. The ultimate goal is to explore how we might manipulate these mechanisms to develop more effective cancer treatments and improve the quality of life of patients with advanced cancer. We’ll be covering a wide range of topics including alterations in peripheral tissue function and the metabolic and inflammatory changes they induce, immune system performance, and cancer cachexia. This conference will be relevant for anyone with an interest in cancer biology, inter-organ communication, the role of cytokines, chemokines, and hormones in cancer, as well as cancer-induced changes in behaviour and metabolism.

Join us online on 25 and 26 February to learn more about this fascinating topic! Submit your abstract before 13 January and register before 03 February to secure your place.

Conference Officer: Hannah Barrs;     Phone: [N/A];     Email: hannah.barrs@eacr.org

cancer research, oncology, cancer biology, immunology, cancer cachexia, inter-organ communication, liver function, muscle function, adipose tissue function, tissue function, metabolic changes, inflammatory changes, tumour metastasis, novel therapeutic interventions, cytokines, chemokines, hormones, cancer metabolism

Biology,    Immunology and Allergic Diseases

Infonet

4th International Cancer Expo and Conference welcomes you as our guest to the City of Philadelphia, USA during March 06- 08, 2025. iCancer Conference 2025 has a theme "Innovations in Cancer Research".

Phone: [06172752612];     Email: jessie@icancerconference.org

Keywords: Conference, Cancer, oncology, Oncology - Medical, oncology meetings, Cancer Conference, Philadelphia, Breast cancer conference Cancer genes, Chemotherapy, Hypoxia, Sarcomas, Lung Cancer, Oral Cancer, Bladder Cancer, Skin Cancer, Hematology, Medical Imaging, Prognosis, Radiotherapy, clinical trials, Epidemiology, Breast cancer, Cancer, Geneticist, Immune system, Pathologist, Prosthesis, Thermography, X-ray, Biopsy,

Verein fuer Leukaemieforschung und -Therapie e.V. Muenster together with Klinikum Großhadern, Munich,Germany

The symposium is taking place again in Munich, Germany, in-person from Sunday, March 16 until Wednesday, March 19, 2025. Additionally to the XI Main Sessions two free contributions sessions MS V (Poster session) and MS IX (Best of Free Contributions Session) will additionally deliver the possibility to all those who want to present their own research data in form of a free contribution and discuss their findings with the worldwide most renowned scientists and researchers in the field of acute leukemias. We therefore encourage all who are interested in actively participating in ISALXIX with a free contribution to submit their abstract(s). All accepted abstracts will be part of the open access ISALXIX supplement published in ANNALS OF HEMATOLOGY and in the Poster Viewing and Discussion Session (MSV). Abstract Submission Deadline: October 31, 2024.

Organizing Office Beate Buske-Kosel;     Phone: [+49 160 615 1531];     Email: info@acute-leukemias.de

MS I: Biology of Acute Leukemias MS II: Biology in Acute Leukemias MS III: Genetic and Molecular Characterization of AML: Novel Markers for Diagnosis and Prognosis MS IV: Novel Approaches and Targeted Therapies in AML MS VI: Risk adapted Therapy of AML MS VII: Biology and Treatment of APL MS VIII: MRD in Acute Leukemias: Methods and Clinical Applications MS X: Immunotherapy for Acute Leukemias MS XI: ALL: Biology and Treatment Strategies

The European Association for Cancer Research

This meeting will explore the burgeoning field of cancer persister cells, a rare subset of cells which have emerged over the last decade as a significant factor in cancer treatment failure. Unlike resistance cells, which harbour genetic alterations enabling survival despite therapy, persister cells exhibit transient drug tolerance through reversible, non-mutational mechanisms. Our conference on this topic will bring together investigators from across the world to delve into molecular mechanisms, therapeutic targets, and emerging clinical implications of cancer persister cells, fostering collaboration and community-building in this pivotal and rapidly growing area of research.

Email: christopher.iliffe@eacr.org

cancer research, oncology, cancer persister cells, cancer resistant cells, non-genetic drug resistance, treatment response, treatment success, treatment failure, molecular mechanisms of resistance and persistence, novel study methodologies, targeting vulnerabilities within persister cells, clinical implications and applications

Pharmacology and Drug Development,    Molecular Biology

The European Association for Cancer Research (EACR)

One of our most popular conferences, Defence is the Best Attack 2025 will be our fifth edition on this topic. Participants will learn about the most recent advances in the field of immunotherapy from the basic science to clinical studies, including the identification of novel targets. You will gain an improved understanding of the mechanisms of action of therapeutic interventions, and benefit from discussions about biomarkers of response to treatment and mechanisms of intrinsic and acquired resistance to immunotherapy.

Conference Officer: Hannah Barrs;     Email: hannah.barrs@eacr.org

cancer research, oncology, immunotherapy, immune-oncology, molecular oncology, tumour-immune system interactions, novel therapeutic approaches, basic cancer research, clinical cancer research, treatment response biomarkers, intrinsic treatment resistance mechanisms, acquired treatment resistance mechanisms, immune checkpoints, microbioma, vaccines, immune cell therapies.

European Molecular Biology Organization (EMBO)

The i-Cancer Congress is a premier international event scheduled to take place in Toronto, Canada on May 26-27, 2025. This congress brings together leading experts, researchers, healthcare professionals, and industry leaders in the field of oncology to discuss and share the latest advancements in cancer research, treatment, and care. The i-Cancer Congress offers an unparalleled opportunity to stay updated on the latest trends and developments in oncology. Attendees will benefit from educational sessions, networking opportunities, and exposure to innovative solutions and technologies shaping the future of cancer treatment. This event is designed to enhance knowledge, foster collaboration, and inspire new approaches to combat cancer.

Phone: [02032898567];     Email: info@icancercongress.com

Cancer Research, Immunotherapy, Oncology, Clinical Research, Lung Cancer, Breast Health, Cancer Prevention and Early Detection, Supporting Cancer Patients and Survivors, Clinical Studies, Cancer Immunity and Immunotherapy, Precision Medicine and Cancer Treatment, Gynaecologic Cancer, Neuro-Oncology and Neurosurgical Oncologys

Spectus meetings World

We are delighted to extend a warm greeting for the 2nd International Conference on Cancer and Oncology Research, (World Cancer 2025 ) which will be held in the famous city Barcelona, Spain on June 23-24, 2025, organized in coordination with generous support and cooperation from passionate academicians and organizing committee members with the theme “Raising Wings to Promote Cancer Free World".

Phone: [1 302 308 5943];     Email: worldcancer@spectusconferences.com

Conference Sessions Tumor heterogeneity and Cancer Metastasis Translational Biology to Medicine in Innovative oncology Immune Responses & DNA Repair - Cancer Fields Cancer Genetics Surgical Oncology Single-cell and Spatial Multiomics in Cancer Research Cancer Prevention & Research Cancer Signaling Next Generation Cancer Models Cancer Imaging Techniques Radiation Oncology Gynecologic Cancer Cancer treatment & palliative care Pediatric Oncology Cancer Immunology & Immunotherapy Breast cancer Computational Analysis of Cancer Nanopore Sequencing of Cancer Genomes Biomarkers in Cancer Organ-Defined Cancers The Application of Clinical Proteomics for Precision Oncology Drug Resistance in Cancer Cancer Genetics and Epigenetics Cancer Diagnostics: From Research to Clinical Practice Advanced Therapies in Cancer Cancer Diagnosis and Screening Cancer Science and Targeted Therapies Cancer Science and Therapeutics Organ Specific Cancer Pharmacology in Cancer AI in Cancer Control Tobacco control Cancer diagnosis and care

Fusion

Laura Trundle, Director;     Email: laura@fusion-conferences.com

DNA Damage Response, cancer biology, replication stress, cancer therapies, PARP inhibitors, BRCA, clinical development

Molecular Biology,    Genomics and Bioinformatics

EMBL Heidelberg

This meeting will provide an opportunity to learn about and keep up to date with the rapidly progressing area of cancer genomics. We aim to bring together scientists from across several disciplines connected with cancer research, for a unique opportunity to interact and stimulate further integration of these efforts.

EMBL Events;     Email: events@embl.de